BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18319313)

  • 1. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
    Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
    J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice.
    Peluso JJ; Gawkowska A; Liu X; Shioda T; Pru JK
    Endocrinology; 2009 Nov; 150(11):4846-54. PubMed ID: 19797399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling.
    Zhu X; Han Y; Fang Z; Wu W; Ji M; Teng F; Zhu W; Yang X; Jia X; Zhang C
    Oncol Rep; 2013 Nov; 30(5):2488-94. PubMed ID: 23970345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action.
    Peluso JJ; Pappalardo A; Losel R; Wehling M
    Endocrinology; 2006 Jun; 147(6):3133-40. PubMed ID: 16513825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion.
    Peluso JJ; Liu X; Gawkowska A; Johnston-MacAnanny E
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2644-9. PubMed ID: 19417032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment.
    Zhu X; Ji M; Han Y; Guo Y; Zhu W; Gao F; Yang X; Zhang C
    Int J Oncol; 2017 Mar; 50(3):835-846. PubMed ID: 28197632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1.
    Albrecht C; Huck V; Wehling M; Wendler A
    Steroids; 2012 Dec; 77(14):1543-50. PubMed ID: 23064006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis.
    Lodde V; Peluso JJ
    Biol Reprod; 2011 Apr; 84(4):715-22. PubMed ID: 21148105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
    Sueldo C; Liu X; Peluso JJ
    Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations.
    Peluso JJ; Romak J; Liu X
    Endocrinology; 2008 Feb; 149(2):534-43. PubMed ID: 17991724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AG 205, a progesterone receptor membrane component 1 antagonist, ablates progesterone's ability to block oxidative stress-induced apoptosis of human granulosa/luteal cells†.
    Will EA; Liu X; Peluso JJ
    Biol Reprod; 2017 Apr; 96(4):843-854. PubMed ID: 28371915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
    Friel AM; Zhang L; Pru CA; Clark NC; McCallum ML; Blok LJ; Shioda T; Peluso JJ; Rueda BR; Pru JK
    Cancer Lett; 2015 Jan; 356(2 Pt B):434-42. PubMed ID: 25304370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer.
    Peluso JJ
    Steroids; 2011 Aug; 76(9):903-9. PubMed ID: 21371489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant role of nuclear progesterone receptor in the control of rat periovulatory granulosa cell apoptosis.
    Friberg PA; Larsson DG; Billig H
    Biol Reprod; 2009 Jun; 80(6):1160-7. PubMed ID: 19208546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
    Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
    Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
    Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone's ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cells.
    Peluso JJ; Yuan A; Liu X; Lodde V
    Biol Reprod; 2013 Jan; 88(1):20. PubMed ID: 23242527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism.
    Engmann L; Losel R; Wehling M; Peluso JJ
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4962-8. PubMed ID: 16984987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.
    Ahmed IS; Rohe HJ; Twist KE; Mattingly MN; Craven RJ
    J Pharmacol Exp Ther; 2010 May; 333(2):564-73. PubMed ID: 20164297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.